These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 37414735)

  • 1. Unravelling the Mystery of COVID-19 Pathogenesis: Spike Protein and Cu Can Synergize to Trigger ROS Production.
    Katarzyna Lesiów M; Witwicki M; Tan NK; Graziotto ME; New EJ
    Chemistry; 2023 Oct; 29(55):e202301530. PubMed ID: 37414735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.
    Meyer K; Patra T; Vijayamahantesh ; Ray R
    J Virol; 2021 Aug; 95(17):e0079421. PubMed ID: 34160250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
    Zaheer M; Ali N; Javed H; Munir R; Jamil N
    J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical Investigation of the Coronavirus SARS-CoV-2 (COVID-19) Infection Mechanism and Selectivity.
    Biskupek I; Sieradzan A; Czaplewski C; Liwo A; Lesner A; Giełdoń A
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
    Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
    Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    Sevenich M; van den Heuvel J; Gering I; Mohrlüder J; Willbold D
    J Virol; 2022 Jul; 96(13):e0068522. PubMed ID: 35674432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics.
    Yesudhas D; Srivastava A; Gromiha MM
    Infection; 2021 Apr; 49(2):199-213. PubMed ID: 32886331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects.
    Mahmoudi S; Dehkordi MM; Asgarshamsi MH
    Biophys Chem; 2022 Sep; 288():106824. PubMed ID: 35728510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron variant in COVID-19 current pandemic: a reason for apprehension.
    Kamble P; Daulatabad V; Patil R; John NA; John J
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):89-96. PubMed ID: 36064193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells.
    Singh AV; Kayal A; Malik A; Maharjan RS; Dietrich P; Thissen A; Siewert K; Curato C; Pande K; Prahlad D; Kulkarni N; Laux P; Luch A
    Langmuir; 2022 Jul; 38(26):7976-7988. PubMed ID: 35736838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.